- MyIllumina
- Tools
"The Illumina Gene Expression workflow gives us the convenience and time savings of running multiple samples at once."
Rachel Adams
Research Associate, Genomics, Proctor & Gamble
Rachel Adams is a research associate in the genomics research team at Procter & Gamble (P&G). This group provides genomic analysis resources for product developers to understand the molecular basis behind consumer products of interest.
Other Profiles
Q&A with Rachel Adams
How do you use Illumina products in your research?
With Illumina’s HumanHT-12 Expression BeadChip, expression levels for tens of thousands of genes can be generated simultaneously to look for exciting new targets and identify new applications for known ingredients. The genomic research that goes into many of P&G’s product lines are scientifically validated, published in peer-reviewed journals, and examined in real clinical studies.
What are the advantages of the Illumina Gene Expression workflow?
The Illumina workflow works well for us. I like that you can wash and stain 96 samples at the same time. It adds convenience in that all you have to do is load your chips and scan after an hour or so of hands-on time. While scanning chips, I can work on another project, which is something we haven’t been able to do in the past.
What can Illumina do to help you prepare for future studies?
We are currently using the BeadArray Reader and we’re interested in increasing our array throughput. Decreasing the scan time without sacrificing quality would be beneficial. We are also interested in improving the lifespan of the chips.
Researcher Bio
Rachel Adams is a research associate in the genomics research team at Procter & Gamble (P&G). This group provides genomic analysis resources for product developers to understand the molecular basis behind consumer products of interest. With Illumina's HumanHT-12 Expression BeadChip, expression levels for tens of thousands of genes can be generated simultaneously to look for exciting new targets and identify new applications for known ingredients. The genomic research that goes into many of P&G's product lines are scientifically validated, published in peer-reviewed journals, and examined in real clinical studies.
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.